19 employees
ViraTherapeutics develops highly potent anti-cancer therapeutics based on oncolytic viruses.
2013
$4M
from 1 investors over 1 rounds
ViraTherapeutics GmbH raised $4M on June 24, 2015
Investors: EMBL Ventures